Serum prohepcidin concentrations in rheumatoid arthritis

Area of Science:

• Hematology
• Immunology
• Endocrinology

Background:

• Hepcidin is a key regulator of iron metabolism and a mediator of anemia of inflammation.
• Distinguishing iron deficiency from anemia of inflammation is crucial for effective treatment.

Purpose of the Study:

• To evaluate serum prohepcidin as a biomarker to differentiate iron deficiency anemia (IDA) from anemia of inflammation in rheumatoid arthritis (RA) patients.

Main Methods:

• Serum prohepcidin and soluble transferrin receptor (sTfR) levels were measured in healthy donors, RA patients with anemia, and IDA patients.
• Patients were categorized based on iron status (depleted vs. repleted) using ferritin levels.

Main Results:

• Serum prohepcidin was significantly lower in IDA patients compared to controls.
• RA patients with iron depletion showed reduced prohepcidin and elevated sTfR, indicative of iron deficiency.
• RA patients with iron repletion had normal prohepcidin levels.

Conclusions:

• Serum prohepcidin is a reliable indicator of uncomplicated iron deficiency anemia.
• Reduced prohepcidin in iron-depleted RA patients suggests iron deficiency, despite potential conflicting regulatory signals in RA.